Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05434013 · ClinicalTrials.gov registry record · NA
The Impact of Cigarillo Warnings on Purchasing
A NA study of Cigar Smoking, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 1,578
- Enrollment target
- 1
- Study location
NCT05434013 is a NA study of Cigar Smoking that has completed, run by Boston University. The registered enrollment target is 1,578 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05434013, a NA study of Cigar Smoking, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,578 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether different cigarillo warning formats (pictorial, FDA-proposed text-only, current Surgeon General text-only) reduces demand for cigarillos. A previous study has identified that pictorial cigarillo warnings are perceived as more effective, but more information is needed on their impact. This study will address this issue by randomizing participants to see different cigarillo warning formats on cigarillo products within an online experimental tobacco marketplace. Participants will be cigarillo users who are ages 21-35.
Conditions Studied
Interventions
- BEHAVIORAL Cigarillo warnings-Surgeon General Text-Only
- BEHAVIORAL Cigarillo warnings-FDA proposed text-only
- BEHAVIORAL Cigarillo warnings-Pictorial
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,578 participants |
| Start Date | 2022-06-24 |
| Est. Completion | 2022-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05434013
The ClinicalTrials.gov registry entry for NCT05434013 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,578 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cigar Smoking appearing as the primary indexed condition, and to 3 interventions - of which Cigarillo warnings-Surgeon General Text-Only is the first listed.
NCT05434013 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05434013 about?
NCT05434013 is a clinical study titled "The Impact of Cigarillo Warnings on Purchasing". The purpose of this study is to determine whether different cigarillo warning formats (pictorial, FDA-proposed text-only, current Surgeon General text-only) reduces demand for cigarillos. A previous study has identified that pictorial cigarillo warnings are perceived as more effective, but more info...
What is the current status of trial NCT05434013?
This trial is currently completed. It is a NA study. The enrollment target is 1,578 participants. The study started on 2022-06-24. Estimated completion is 2022-07-21.
What conditions does trial NCT05434013 study?
This clinical trial studies the following conditions: Cigar Smoking.
What interventions are being tested in trial NCT05434013?
The interventions under investigation include: Cigarillo warnings-Surgeon General Text-Only (BEHAVIORAL), Cigarillo warnings-FDA proposed text-only (BEHAVIORAL), Cigarillo warnings-Pictorial (BEHAVIORAL).
Who is sponsoring clinical trial NCT05434013?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05434013 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigar Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.